BENGALURU: After an unsuccessful bid two months ago, India may attempt another soft landing on the Moon by next year-end, probably in November, sources in ISRO said on Thursday.
The Indian Space Research Organisation had constituted a high-level committee, headed by S Somanath, Director of Thiruvanathapuram-based Vikram Sarabhai Space Centre, the lead centre responsible for all launch vehicle programmes of ISRO, to prepare a report on the proposed Chandrayaan-3.
“The panel’s report is awaited. The committee has been given a guideline to prepare the mission before the end of next year,” a senior ISRO official told PTI.
“There is a good launch window in November”.
“Rover, lander and landing operations will get more focus this time and whatever deficiencies in the Chandrayaan-2 mission will be corrected,” sources in the Bengaluru- headquartered space agency said.
On September 7, ISRO attempted a soft landing of Chandrayaan-2’s ‘Vikram’ on the unchartered lunar south pole, before losing communication with the lander.
A national level committee consisting of academics and ISRO experts, headed by V Narayanan, Director of the space agency’s Liquid Propulsion Systems Centre, has analysed the cause of communication loss with the lander.
The members of the panel included those from VSSC and U R Rao Satellite Centre.
“This committee has pin-pointed as to what went wrong. They have prepared a voluminous report and are believed to have submitted it to the Space Commission,” an ISRO official said.
“It’s expected to be put in the public domain after the approval of the PMO,” the official said.
Source: ET
Image Courtesy:OutlookIndia
You may also like
-
New Heat-Based Approach To Cancer Treatment Can Reduce Chemotherapy Doses
-
Scientists Take A Major Step Towards Unification Of Classical & Quantum Gravity
-
India Graphene Engineering and Innovation Centre (IGEIC) Under the Vision of Viksit Bharat@2047 Launched
-
New High-Performance Gas Sensor can Monitor Low Level Nitrogen Oxides Pollution
-
Antidepressant Drug can be Repurposed for Treating Breast Cancer